Vericel (VCEL) Total Debt Growth (1y) (2011 - 2018)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 52.07% |
| Jun 30, 2018 | 109.29% |
| Mar 31, 2018 | 70.33% |
| Dec 31, 2017 | 2,107.40% |
| Sep 30, 2017 | 1,138.43% |
| Jun 30, 2017 | 15,763.46% |
| Mar 31, 2017 | 16,230.65% |
| Dec 31, 2016 | 1,042.25% |
| Sep 30, 2016 | 764.20% |
| Jun 30, 2016 | -42.86% |
| Mar 31, 2016 | -38.00% |
| Dec 31, 2015 | -84.46% |
| Sep 30, 2015 | -47.06% |
| Jun 30, 2015 | -96.36% |
| Mar 31, 2015 | 4,900.00% |
| Dec 31, 2014 | 7,516.67% |
| Sep 30, 2014 | 1,430.00% |
| Jun 30, 2014 | 13,057.89% |
| Mar 31, 2014 | -93.10% |
| Dec 31, 2013 | -85.00% |
| Sep 30, 2013 | -79.59% |
| Jun 30, 2013 | -67.80% |
| Mar 31, 2013 | -57.97% |
| Dec 31, 2012 | -50.00% |
| Sep 30, 2012 | -51.00% |
| Jun 30, 2012 | -59.59% |
| Dec 31, 2011 | -68.63% |